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Expression of an Epitope as Detected by the Novel 
Monoclonal Antibody 4F7 on Dermal 
and Epidermal Dendritic Cells. 
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Dendritic Cell In Situ 
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Ears of Balb/c mice were treated epicutaneously with 0.5% 
2,4-dinitrofluorobenzene (DNFB) to obtain monoclonal an-
tibodies characterizing molecules on epidermal dendritic 
cells that are involved in the induction and elicitation of 
allergic contact dermatitis. Six hours after this treatment, 
epidermal cells were prepared from the ear skin, and la-posi-
tive cells were enriched by indirect panning and injected into 
rats. 
Hybridomas were generated and supernatants were 
screened for antibodies on ear skin from DNFB-treated and 
untreated animals. A clone (4F7) was isolated and character-
ized by immunohistochemistry and immunoelectron mi-
croscopy on murine skin and other organs. The monoclonal 
antibody 4F7 (IgG1) recognized distinct dendritic cells in the 
dermis and very few dendritic cells in the paracortical area of 
the lymph nodes, the white pulp of the spleen, and the mu-
cosa of the large intestine in normal animals. By fluorescence 
activated cell sorter analysis, it stained about 1.64% of the 
. dermal and no epidermal cells in the skin of untreated ani-
A llergic contact dermatitis is mediated by primed T cells that induce a specific .inflammation after contact with hapten [1]. Activation of the antigen-specific T lym-phocyte requires presentation of the antigen in associ-ation with major histocompatibility comrlex (MHC) 
class II antigen on antigen-presenting cells (APCs) [1 . 
Additional signals are provided by factors such as interleukin (IL) 
1 and 2, adhesion molecules [2], and other co-stimulatory signals, 
which are not clearly defined. Some of these stimulatory activities 
may be induced by contact sensitizers in APCs or other accessory 
cells such as macrophages, keratinocytes, or endothelial cells. It has 
been shown that contact sensitizers induce in Langerhans cells 
(LCs) receptor-mediated endocytosis [3,4], loss of membrane aden-
osine-5' -triphosphate (ATP)ase activity [5], and possibly migration 
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mals. Approximately 50% of the dermal4F7+ cells expressed 
Ia molecules on their surface. 
Six hours after application of 0.5% DNFB, the expression 
of the 4F7 antigen was strongly enhanced in vivo on dendritic 
cells in both the dermis and epidermis. About 15% of the 
epidermal dendritic cells expressing 4F7 exhibited Birbeck 
granules, the other Birbeck granule-negative cells resembled 
indeterminate dendritic cells (IDes). 
The de~mal an~ epidermal 4F7~ cells could be highly 
(98%) ennched With 4F7-labeled lmmunomagnetic parti-
cles. Transmission electron microscopic analysis of such 
preparations showed typical characteristics of dendritic cells 
with 50% or 100%, respectively, of these cells expressmg Ia 
molecules on their cell membrane. The results suggest that 
the 4F7 epitope is expressed on dendritic cells related to 
Langerhans cells and is upregulated by an inflammatory 
stimulus. Key words: allergic contact dermatitis/DNFBJ 
4F7+ cells.] Invest DermatoI101:832-838, 1993 
of the cells into the draining lymph node [6]. This indicates that 
contact sensitizers are able to activate mechanisms in LCs that may 
be relevant for sensitization. The nature of these costimulatory 
mechanisms and the molecules involved are not clearly understood. 
To identify molecules that are induced on Ia+ epidermal cells 
shortly after application of a contact sensitizer onto the skin of 
non-sensitized mice, we generated monoclonal antibodies (MoAbs) 
to epidermal cells enriched for Ia+ dendritic cells from mice treated 
with the contact sensitizer 2,4-dinitrofluorobenzene (DNFB). A 
MoAb was isolated that reacted with an epitope on Ia+ dermal den-
dritic cells (DCs) of DNFB-untreated mice. This epitope was upre-
gulated and also found on epidermal DCs, some of which resembled 
LCs, after DNFB application. 
MATERIALS AND METHODS 
Animals Balb/c mice were purchased from the Zentralinstitut fur Ver-
suchstierkunde in Hanover, Germany. For our experiments we used femal e 
mice at an age of 8 -12 weeks and DA/HA rats from the same institute about 
8 weeks old for immunization. 
Culture Medium RPM! 1640 (Biochrom KG, Berlin, FRG) supple-
mented with 10% fetal calf serum and 20 JIg/ml gentamycin (borh 
Biochrom KG) was used. 
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A.ntibodies MKD6 (anti-I-Ad [7]) was obtained from American Type 
Culture Collection (ATCC, Rockville, MD), goat-anti-rat polyclonal anti-
body conjugated with beads .from Dianova (Ham~mrg, Germany), and 
sheep - anti-rat peroxidase-conJugated polyclonal antibody from Amersham 
(Braunschweig, Germany) . 
Preparation of LC-Enriched Epidermal Cells Epidermal cells were 
repared by the method. described by Liu an~ Karasek [8]. Briefly, DNFB 
fo.S% in acetone/olIve 0114:1, Sigma, St. LoUIS, MO) was painted onto both 
sites of the ears and abdominal skin of Balb/c mice [?). After 6 h, the ears 
were collected, placed in 70% ethanol for S sec, and rinsed With cold phos-
hate-buffered saline (PBS) three times. The ears were split in ventral and 
~orsal halves using line tweezers and incubated separately from the ab?omi-
al skin, which was cleaned accurately from the subcutaneous tIssue. Smgle-~eIl suspensions were prepared by a c.ombined trypsin/ dispase digestio~ 
according to Kitano a~d Okada [10]. Bnefly, t~e ear halves and the abdotnl-
aI skin were placed 1Il PBS supplemented with 2.5 U/ml dlspase type II 
(Boehringer Mannheim, Germany) and incubated at 37·C in PBS contain-
'ng 0.2% trypsin type III (w/v) (Sigma) and 0.1% EDTA (w/v) (Serva, 
Heidelberg, Germany) with gentle agitation for 15 min. This procedure 
ensured a convenient separation of the epidermis fr~m the dermis. ~he 
dermis was discarded willie the epidermiS was mechamcally shredded usmg 
fine forceps. A single-cell suspensio,:," was o.btained by filtering the . cells 
hrough a stainless steel mesh. The residual epidermal fragments were nnsed 
~nce with RPM! 1640/10% fetal calf serum (FCS) and discarded. After 
assage of the resulting suspension through the mesh, both cdl suspensions ~ere combined. Cells were sedimented at 250 Xg for 10 nun at 4·C and 
washed twice with RPM! 1640/10% FCS. . 
per mouse, 2.5 X 107 cells (viability 98%) were obtained. Bulk epidermal 
cells (106 /m!) were suspended in ~.~I1640, supplemented with 10% FCS, 
2 roM glutamine, 100,ug/ml penlCllhn/streptomycm, 50,ug/ml gentamy-
cin, and were placed in polystyrene Petri d!shes for short-term tissue. cul.ture 
over various periods of tiI?e. LCs were e~nched to about 30% by an mdlrect 
paJUling protocol accordmg to WysockI and Sato (11). 
Production of Monoclonal Antibodies The enriched LCs (5 X.106 -
1 >< 107 ) were injected into DA/HA rats subcutaneously and IIltrapen.tone-
ally. After aLI immunization period of 4 months with six subsequent IIlJec-
'ons of cells, the rats were killed and the spleen was removed. The isolated l~mphocytes were fused with Ag8 myeloma cells (American Type Culture 
Collection CRL 1580) in the presence of polyethylene glycol (PEG 4000, 
Boehringer Mannheim) following standard methods [12]. 
Subsequently, the screening of.the hybridoma .clones was perf?nne.d by 
'mJIlunohistology on cryostat sectIOns from ear skill ofBALB/c mice, either 
:mtreated ot ·treated with DNFB as described above. 
Jrnn1unohistochemistry Ears ~ro~ ~NF.B-, acetone/olive oil-trea~ed, 
and untreated animals were fixed m lIqUid nitrogen and stored at -70 C. 
i\bout 4-.um-thick cryostat sections were incubated with the MoAb 4F7 for 
1 h at room temperature and subsequently incubated with a sheep-anti-rat 
peroxidase-conjugated p.olyclo~al anti~od.y for 1 h atroom temperature. 
The detection of specllic antibody bmdmg was achieved by the substrate 
3_arnino-9-ethylcarbazole (ABC). The whole method is described in detail 
[1:3}. To compare the. 4F7 stainin~ pattern with the la-antigen pattern, the 
specimens were also mcubated With the MoAb MK-D6. For cont~o~ pur-
poses, the sections were Illcubated With normal rat serum and by omiSSIOn of 
[he 4F7 MoAb, respectively. 
Itnmunoelectron Microscopy For immunoelectron microscopy, the 
ears were placed in Nakane's fixative (periodate-lysin-paraformaldehyde) 
for 2 h at 4 · C . After being washed in 0.1 M PBS containing increasing 
concentrations of sucrose, the specimens were rapidly frozen in liquid nitro-
gen. The frozen tissue was cryostat sectioned at 40-,um intervals. The sec-
lions were incubated with the MoAb 4F7 for 2-3 hat 4 · C and then incu-
bated with peroxidase-conjugated goat-anti-rat IgG (dilution 1:25) for 4 h 
It 4· C . Positive reactions were visualized with 3,3-diaminobenzidinetetra-
hydrochloride (Sigma). After immunostaining, the sections were postfixed 
in half-strength Karnovsky's solution for 1 h at 4· C and 1.33% osmic acid 
for 1 h at room temperature, dehydrated in a graded ethanol series, and 
embedded in Epon 812. Ultrathin sections were stained with uranyl acerate 
and lead citrate and were examined with a Philips electron microscope EM 
301 using the double-condensor system: For control purposes, the tissue 
sections were incubated with a polyclonal rar anribody to human Immuno-
globulin (Ig)G or by the omission of 4F7 antibody. 
Isolation of 4F7+ Cells 4F7+ cells were isolated by immunomagnetic 
beads as described by Hanau et al (12). Briefly, the MoAb4F7 was conjugated 
with a goat -anti-rat polyc1onal antibody coupled to immunomagnetic beads 
wd incubated overnight at 4· C on a rotor. This complex was washed three 
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times with PBS/ O.Ol % bovine serum albumin (BSA) to remove the uncon-
jugated antibodies. 
Dermal or epidermal cells (8 X 107) were added to the antibody complex, 
then incubated for 30 min at 4·C On a rotor. After 30 min, a magnetic field 
was applied and the non-binding cells were removed. The sediment was 
then washed 10-15 times with RPM! 1640/10% FCS. The cells were 
purified by this method to > 99%, as determined by immunocytologic stain-
ing with MoAb 4F7, and subjected to ultrastructural and flow cytometric 
analyses. 
Ultrastructural Analysis The cells were fixed ill Nakane's fixative (per-
iodate-lysin-paraforma.ldehyde) for 10 min at room temperature. Routine 
electron microscopy was performed on cell preparations that were subse-
quently postfixed in 1.33% osmic acid (0.05 M PBS, pH 7.4) for 20 min, 
dehydrated in a graded ethanol series, and embedded in Epon 812 using 
beam capsules. Ultrathin sections were stained with uranyl acetate and lead 
citrate and were examined with the electron microscope. 
For immunoelectron microscopy, the cells were pre incubated with 1 % 
BSA in 0.01 M PBS and incubated with a monoclonal rar antibody against 
murine Ia molecules (Hybritech, San Diego, CA) for 1 h at room tempera-
ture. The antibody was solved in 0.01 M PBS containing 1 % BSA. After 
being washed in the PBS, the cells were incubated with 10 nm gold-labeled 
goat-anti-rat IgG iu 0.01 M PBS (1 % BSA, 10% normal goat serum, 40/0 
normal mouse serum) for 1 h at room temperature. The reaction was stopped 
by rinsing the cells in 0.01 M PBS. The specificity oflabcling was controlled 
by incubating the cells with a polyclonal rat antibody against human IgG aud 
the gold complex. After immunolabeling, the cells were processed in a 
manner similar to that described for routine electron microscopy. 
Flow Cytofluorometric Analysis The cells (106/ tube) were fixed with 
1 % paraformaldehyde in PBS without Ca++ / Mg++ ions, pH 7.1, at 20·C for 
15 min under continuous gentle agitation. After washing three times in 1 mI 
PBS/O.l % Natriumazid/0.2% BSA, the cells were suspended in 500,u1 
culture supernatant of MoAb 4F7, or in a MoAb solution from the same 
isotype (IgG,), for 30 min at 4· C. Following three washes with the PBS/ 
BSA solution, 100,u1 of fluorescein isothiocyanate (FITC)-conjugated 
goat-anti-rat IgG F(ab')" (diluted 1:200) in PBS/BSA solution were added, 
and the suspension was incubated for 30 min at 4· C. After three final 
washes, the cells were analyzed using a Becton Dickinson FACS. Per histo-
gram, 105 cells were monitored. 
To analyze double-stained dermal and epidermal cells, these were set up to 
1 X 106 cells per 100 ttl fluorescence activated cell sorter (FACS) medium 
per experiment, lixed for 10 min in paraformaldehyde at room temperature, 
and subsequently washed in FACS medium. To each cell pellet, 500 ,ul of an 
antibody suspension, mixed at equal parts with MoAbs 4F7 and MK-D6, was 
added. In parallel, a sample with 500 ttl of isotype antibody suspension, also 
mixed at equal parts with anti-rat and anti-mouse antibody suspension, was 
set up for staining the negative and unspecific binding sites. The incubation 
time was also 15 min on ice, followed by three washes and uptake of the 
pellets in 100,u1 FACS medium. Finally, the samples were mixed with each 
100 Itl FITC-conjugated anti-mouse IgG (Sigma), 1:200, aud 100,u1 phy-
coerythrin (PE)-cOl~ugated anti-rat IgG, 1:100, (Southern Biotechnology 
Association Inc.), incubated 15 min on ice, washed three times, and then 
taken up in 500,u1 FACS medium. 
RESULTS 
Immunohistochemistry The supernatants from a number of 
clones were screened on ear cryosections from BALB / c mice treated 
with 0.5% DNFB or with acetone/olive oil. A done was selected 
producing an antibody weakly staining a few dendritic-appearing 
cells in the dermis of untreated mice and showing a strong reaction 
in the dermis and epidermis of D NFB-trea ted animals. This clone 
was recloned and a MoAb (4F7) was obtained. This antibody (sub-
class IgGJ) was used at a concentration of 10 Jig/m!' 
In normal skin, incubation with 4F7 MoAb resulted in staining of 
few dermal cells, mostly located in close apposition to the dermal 
blood vessels. The cells showed a dendritic- like structure (Fig la). 
Six hours after application of DNFB, the staining reve:JJed a 
significant increase of similar cells in the dermis and epidermis, too 
(Fig 1b). Moreover, these cells appeared slightly larger than the cells 
in untreated skin. 
The occurrence of 4F7+ cells in several organs was studied by 
immunohistochemistry (Fig 1 and Table I). 
The 4F7 epitope was expressed on few cells in the paracortex of 
the lymph nodes (Fig l c), the white pulp of the spleen, and the 
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Figure 1. Immunohistochemical appearance of 4F7+ cel ls. a) Ear skin of untreated Balb/c mice: positive staining of dermal cells. b) Ear skin ofDNFB-treated 
Balb/c mice: staining of dermal and epidermal cel ls. c) Lymph node, untreated mice: few, positive dendritic cells in the paracortical area. d) Colon, untreated 
mice: staining of single dendritic cells in the mucosa. 
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Table 1° 
Pineal gland: negative 
Pituitary gland: negative 
Thymus gland: negative 
Thyroid gland: negative 
Adrenal gland: negative 
Sciatic nerve: negative 
Eye: negative 
Colon: very few, mucosa 
Lymph node: few, paracortical area 
Spleen: few, white pulp and marginal zone 
Peritoneal macrophages: negative 
• The 4F7 epitope recognized a few labeled cells in the paracortical areas of the lymph 
nodes. The white pulp and especially the marginal zone of the spleen contained some 
4F7+ cells characterized by dendritic morphology. In the mucosa of the colon very few 
cells were recognized. In the other tissues screened , no 4F7+ cells were dctecteO. 
mucosa of the colon (Fig Id). All labeled cells showed a dendritic 
structure. 
ReITlarkably, there was no increase of the 4F7+ cells in the drain-
ing lyITlph nodes after DNFB application onto the ears of non-sen-
sitized and sensitized mice. 
l11lIuuuoelectroll Microscopy On immunoelectron micros-
copy, the incubation with the 4F7 MoAb did not stain any epider-
rnal COITlponent of normal mice. There was no labeling ofkeratino-
cytes, ITlelanocytes, Merkel cells, and Langerhans cells . 
. ". 1-' ..... - ... ~ . 
Figure 2. Irnmunoelectron microscopy. a) 4F7+ dermal ce ll in untreated 
ar skin showing electron·dense peroxidase labeling of the ce ll membrane. 
Note the lobulated nucleus, the wel l-organized cytoplasm without Birbeck 
granules, and the intersectioned dendritic processes (magnification X 8500). 
&) 4F7+ epidermal cel l 6 h after DNFB app lication. The labeled dendritic 
,dl demonstrates some cytoplasmic Birbeck granules (arrow) (magni-
fication X 9500). 
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Figure 3. 4F7-enriched dermal dendritic cells on electron microscopy. a) 
Typical dendntlC feature of the cells (magnification X 9500). b) Ia expres-
sIOn of the cel l membrane as detected by immunogold labeling (magni-
fication X 57,000). 
TI~e dermis regularly showed some cells with a dark peroxidase 
reactIOn product on their surface (Fi g 2). These cells were charac-
terized by a centrally located, slightly lobulated nucleus and a spin-
dle to round-oval outer shape. The plasma membrane of the cells 
exhibited numerous short villous projections. The cytoplasm con-
tained some mitochondria, smooth and rough endoplasmatic mem-
branes, and few, if any lysosomes. The Golgi region of the cells was 
often prominent with electron-lucent, non-coated ves icles. No Bir-
beck granules were observed in the cytoplasm of the cells (Fig 2a). 
In normal mice, only few labeled cells were found in the entire 
dermis . The application of 0.5% DNFB resulted in an increased 
number of 4F7+ dermal cells and these cells often appeared larger 
than in the controls. A significant proportion of these activated cells 
were associated with the dermal capi llaries. Six hours after applica-
tion of DNFB, single 4F7+ cell s also appeared in the basal and 
suprabasal epidermis. On electron microscopy, these cells resem-
bled indeterminate dendritic cells (IDCs). Moreover, about 15% of 
these cells showed typical Birbeck granules of LCs (Fig 2b) . There 
was no ultrastructural activation (such as increased numbers of en-
836 MOHAMADZADEH ET AL 
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Fluotescence inlensity 
Figure 4. FACS analysis of 4P7 epitope on 4F7+ dermal dendritic cells 
from untreated skin. Freshly prepared dermal cells were fixed with parafor-
maldehyde, incubated with MoAb 4F7 (IgG,) and, as control isotype, MoAb 
4C8 (lgG, , from our laboratoty), followed by FlTC-labeled goat-anti-rat 
IgG, and were evaluated by PACS analysis. a) Control by an isotype MoAb 
4C8 (0.10%). b) 4F7+ dDC (1.64%). 
docytotic organelles, mitochondria, and endoplasmic membranes) 
of both the dermal and epidermal DCs, including the 4F7+ LCs. 
The 4F7+ cells, isolated from the dermis and epidermis by 4F7-
'Iabeled magnetic beads and studied by electron microscopy, were 
morphologically similar to those identified in situ and described 
above (Fig 3a) . On immunogold labeling for Ia molecules, about 
50% of the dermal and about 100% of the epidermal cells were 
positive. A positive staining of the cell membrane was observed, 
especially in the larger dermal cells. These cells demonstrated a 
weak labeling of the plasma membrane, but did not exhibit a cyto-
plasmic staining (Fig 3b). 
Flow Cytofluorometric Analysis To quantify the cells that are 
recognized by the MoAb 4F7, FACS analysis was performed. The 
cells, isolated enzymatically from dermis and epidermis of untreated 
and treated animals, were taken up in FACS medium, counted, and 
set at 106 cells/l00 ttl . As shown in Fig 4b, about 1.64% of the 
dermal cells were recognized, in Contrast to the control probe with 
an isotype antibody (4C8 from our laboratory) that only conjugated 
with 0.10% of the cells (Fig 4a). 
No 4F7+ cells were detected in epidermal cells of untreated ani-
mals. In contrast, 6 h after treatment with DNFB in vivo, the 4F7 
epitope was expressed on 3.1 % of the dermal and on 1.6% of the 
epidermal cells (Fig 5). 
The double-staining FACS analysis on cells from untreated and 
DNFB-treated Balb/c mice revealed that about 50% of the 4F7+ 
dermal (Fig 6a,b) and 100% of the 4F7+ epidermal cells express Ia 
molecules (Fig 6c,d). 
DISCUSSION 
To identify cell surface molecules on LCs that may be involved in 
the induction of allergic contact dermatitis, we have produced a 
MoAb against LC-enriched epidermal cells obtained from animals 
treated with 0.5% DNFB 6 h before. This time point was chosen 
because some distinct changes of the LCs, such as endocytosis [4], 
apposition of T lymphocytes [14], and the decrease of the ATPase 
activity (5) and Ia+ expression [4], could already be observed 6 h 
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Figure 5. Upregulation of the 4F7 epitope on dermal and epidermal DCs 
determined in epidermal and dermal cell suspensions isolated from the ear 
skin of mice untreated or treated ill lIivo 6 h before with 0.5% DNFB. The 
mean values of three FACS experiments are shown. Standard deviation was 
in the range of 0.1%-0.4%. As control, the isotypc MoAb 4C8 was used. 
after application of a contact sensitizer. We have selected an anti-
body that reacted with an epitope on dermal DCs and, after applica-
tion of DNFB, also on epidermal DCs. 
The molecule recognized by this antibody and observed on den-
dritic cells was upregulated after a single application of a sensitizing 
dose of DNFB. It was also present on dendritic cells in untreated 
animals, however, to a much lesser extent (about 1.64% of all der-
mal cells) and only on dermal dendritic cells. A few scattered cells 
were found in the paracortex of the lymph node, the white pulp of 
the spleen, and in the mucosa of the colon. Remarkably, application 
of a contact sensitizer onto the skin did not result in an increased 
expression of this antigen on lymph node dendritic cells. 
In the skin, the 4F7 epitope appears to be expressed on dendritic 
cells only. This was shown by electron microscopy; other cells such 
as keratinocytes, melanocytes, fibroblasts, or endothelial cells did 
not express this epitope, even after application of a contact sensi-
tizer. The cell expressing this epitope exhibited the typical ultra-
structural features of DCs, such as a centrally located slightly lobu-
lated nucleolus, a plasma membrane with numerous short villous 
projections, a cytoplasma with smooth and rough endoplasmatic 
membranes, and very few Iysosomes. The 4F7+ dDCs were often 
found in close apposition to dermal capillaries. 
In addition to LCs, a number of different DCs have been de-
scribed in the epidermis, dermis, and the draining lymph node, such 
as indeterminate, interdigitating, or veiled cells [15] . All these cells 
belong to a population ofDCs that are bone marrow derived and in 
most cases have antigen-presenting functions [16,17]. 
Sontheimer et al [18,19] have recently reported on a dermal den-
dritic cell that is found in a preferentially perivascular localization. 
This dermal perivascular dendritic cell (DPDC) is Ia+ and stains 
with several MoAbs identifying antigens of the monocyte/macro-
phage lineage (Leu-M5, 63D3, OKM-1), but not with the LC 
marker CDl or T-, B- or NK-cell markers. In addition, its ultra-
structural appearance is not consistent with mast cells or LCs. T he 
cells are able to phagocytize l-)1m latex beads and adhere to plastic. 
Morphology, distribution, and data on the immunophenotype 
(Mohamadzadeh et ai, submitted) indicate that the 4F7+ DC is not 
identical to the DPDC described by Sontheimer. 
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Figure 6. Expression of Ia molecules on dermal and epidermal DCs as demonstrated by FACS ana lysis after double- immunofluorescence labeling with the 
MoAhs 4F7 and MK-D6. a,c) Isotype antibody control (4C8 [IgGd, 10-2.16). b,d) 4F7 and MK-D6 MoAbs. 
As sho"Wn by FACS analysis and immunoelectron microscopy, 
about 50% of the 4F7+ dermal DCs, and 100% of the 4F7+ epider-
rnal Des express Ia molecules, indicating that these cells are capable 
of presenting antigen. The Ia- dermal DCs require further analysis. 
It should be mentioned that culture for 3 d increases the Ia expres-
sion in these cells (Mohamadzadeh et aI, submitted). 
Morphologically, the 4F7+ cells do not resemble veiled cells, 
which have been mentioned as LCs on their way to the draining 
lymph node [6]. In DNFB-treated skin, the 4F7 epitope also ap-
peared on epidermal DCs that could electron microscopically be 
defined as indeterminate cells (cells resembling LCs without Bir-
beck granules). However, 15% of the 4F7+ cells contained few 
Birbeck granules, thus identifying them as LCs. This may indicate 
that LCs and 4F7+ dermal DCs are closely related. 
The exact relationship of the 4F7+ cell to other DCs, particularly 
LCs, and its exact position in the migration pathway of skin DCs 
remain to be analyzed. Efficient methods for the isolation and en-
richment of the cell by means of this antibody have been llsed 
(Moharn.adzadeh et ai, submitted) to elucidate some phenotypical 
and functional properties of this cell and to define its role in contact 
sensitivity and other inflammatory conditions. 
This lVork was Slip ported by a grail! of tlte BIHldesmi"isterillll! fiir ForscluHlg IHld 
Teci/IJologic (BMFT 01 KC 8811). 
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